Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Electrolysis is effective for permanent hair removal, but technique is key to avoid scarring, and sometimes hormonal treatment is needed for women with hirsutism.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Melatonin improved mental health and metabolism in women with PCOS.

Obese women with PCOS are more likely to have fatty liver disease.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.